ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,706Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1019

$1.27M Total Retail Price of All Prescriptions

Rank: 2 out of 1019

680 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 680 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 14,545 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METOPROLOL TARTRATE 1,040 871 1 8
FUROSEMIDE 942 780 2 6
CLOPIDOGREL 862 725 3 7
CRESTOR 853 712 4 13
POTASSIUM CHLORIDE 659 549 5 15
SIMVASTATIN 647 548 6 5
PLAVIX 556 476 7 11
DIGOXIN 415 356 8 14
RANEXA 408 322 9 32
LEVOTHYROXINE SODIUM 397 341 10 25
MELOXICAM 349 295 11 78
CARVEDILOL 323 285 12 3
CLONIDINE HCL 323 275 12 29
ATENOLOL 322 282 14 19
METOPROLOL SUCCINATE 294 277 15 1
METFORMIN HCL 282 217 16 42
NEXIUM 258 204 17 52
KLOR-CON M20 254 211 18 56
HYDROCODONE-ACETAMINOPHEN 249 190 S3 19 36
WARFARIN SODIUM 232 193 20 9
CAPTOPRIL 216 187 21 127
AMLODIPINE BESYLATE 205 185 22 4
RAMIPRIL 190 163 23 21
PRAVASTATIN SODIUM 185 155 24 16
LISINOPRIL 180 138 25 2
CEPHALEXIN 174 141 26 111
ATORVASTATIN CALCIUM 172 147 27 10
MULTAQ 162 145 28 49
PENTOXIFYLLINE 161 140 29 137
ZOLPIDEM TARTRATE 159 109 30 55
OMEPRAZOLE 158 121 31 41
ISOSORBIDE MONONITRATE ER 155 137 32 12
FENOFIBRATE 149 140 33 58
GABAPENTIN 145 121 34 66
JANUVIA 144 114 35 103
CELEBREX 133 110 36 125
LYRICA 126 88 37 152
GLYBURIDE 109 97 R 38 120
PROPAFENONE HCL 108 104 39 64
SUCRALFATE 104 81 40 176
ENALAPRIL MALEATE 97 64 41 38
LOVASTATIN 95 62 42 44
LEVOFLOXACIN 95 76 42 149
PANTOPRAZOLE SODIUM 93 78 44 46
LOVAZA 92 82 45 60
ZETIA 87 81 46 30
EFFIENT 80 66 47 53
SPIRONOLACTONE 78 73 48 23
TRICOR 77 66 49 61
ALLOPURINOL 72 62 50 75
BYSTOLIC 71 60 51 26
TAMSULOSIN HCL 70 58 52 80
LANTUS 67 40 53 141
GLIPIZIDE 64 51 54 119
ALENDRONATE SODIUM 63 59 55 99
AMIODARONE HCL 62 34 56 22
PROMETHAZINE HCL 62 11 R 56 191
CIPROFLOXACIN HCL 60 47 58 98
SINGULAIR 60 58 58 178
CYMBALTA 59 40 60 190
ANTARA 54 52 61 231
BUMETANIDE 54 44 61 74
ADVAIR DISKUS 52 41 63 189
ACTOS 52 46 63 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.